Phio Pharmaceuticals receives Nasdaq notice over minimum bid price noncompliance
PHIO•Phio Pharmaceuticals received a Nasdaq notice on November 16, 2026, after its stock closed below $1 for 30 consecutive business days. It has until May 17, 2027, to regain compliance by closing at or above $1 for at least 10 consecutive business days.
1. Nasdaq compliance period
Nasdaq notified Phio Pharmaceuticals on November 16, 2026, that it did not meet the $1 minimum bid price requirement after its common stock closed below $1 for 30 consecutive business days. The notice does not immediately affect the stock’s listing or trading. Nasdaq gave the company an initial 180-calendar-day period, until May 17, 2027, to regain compliance by maintaining a closing bid price of at least $1 for at least 10 consecutive business days.




